BIONTECH SE - AMERICAN
111.10
08-November-24 13:00:27
15 minutes delayed
Stocks
+3.22
+2.98%
Today's range
110.57 - 115.32
ISIN
N/A
Source
NASDAQ
-
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
20 Mar 2024 06:15:00 By Nasdaq GlobeNewswire
-
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
20 Mar 2024 06:00:00 By Nasdaq GlobeNewswire
-
11 Mar 2024 07:45:00 By Nasdaq GlobeNewswire
-
BioNTech Announces Planned Retirement of Sean Marett
07 Mar 2024 06:45:00 By Nasdaq GlobeNewswire
-
06 Mar 2024 06:45:00 By Nasdaq GlobeNewswire
-
08 Feb 2024 05:45:00 By Nasdaq GlobeNewswire
-
31 Jan 2024 06:45:00 By Nasdaq GlobeNewswire
-
22 Jan 2024 06:45:00 By Nasdaq GlobeNewswire
-
BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference
09 Jan 2024 06:45:00 By Nasdaq GlobeNewswire
-
21 Dec 2023 08:00:00 By Nasdaq GlobeNewswire
-
BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
18 Dec 2023 13:15:00 By Nasdaq GlobeNewswire
-
BioNTech to Inaugurate First African Site on December 18, 2023
12 Dec 2023 06:45:00 By Nasdaq GlobeNewswire
-
BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
06 Nov 2023 06:45:00 By Nasdaq GlobeNewswire
-
26 Oct 2023 06:45:00 By Nasdaq GlobeNewswire
-
23 Oct 2023 11:30:00 By Nasdaq GlobeNewswire
-
23 Oct 2023 06:45:00 By Nasdaq GlobeNewswire
-
BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023
16 Oct 2023 03:30:00 By Nasdaq GlobeNewswire
-
Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs
16 Oct 2023 03:00:00 By Nasdaq GlobeNewswire